We have today announced a strategic investment in Mackworth USA, which reinforces our commitment to expanding our footprint within the US healthcare market.
The investment will accelerate our ambitions in one of the fastest-growing healthcare markets globally. Forging these closer relations with Mackworth USA and its pioneering digital service platform will also enable us to provide market differentiation and strengthen our position across North America.
The move underscores our strong commitment to continued growth and supporting US manufacturing, while simultaneously creating expanded opportunities for our UK facilities to develop and innovate.
Jason Leek, CEO of Prism Healthcare Group, says: “This investment paves the way for us to accelerate our future growth plans. It renews and strengthens our presence as a major force within the rapidly expanding US market.
“Investing in Mackworth USA will bolster our international footprint and reinforce our ability to serve customers, distributors and healthcare systems across North America.”
Charley Wallace, CEO of Mackworth USA, says: “This is an powerful moment for Mackworth. It will enable us to support manufacturing growth in the US and provide the group platform with the opportunity to innovate, expand and continue delivering exceptional products.
“I am delighted to lead Mackworth USA into this new phase of growth within the Prism Healthcare Group.”
This latest investment represents an important step in our journey to become a leading global healthcare solutions provider. With an expanded US presence, enhanced digital capabilities and a continued focus on innovation and manufacturing excellence, we are well positioned to support healthcare systems and improve lives at scale.
